(Q51750678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1 reference

1 reference

José L Jiménez Blanco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Juan M. Benito

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Antonio Díaz-Quintana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

José A Sánchez-Alcázar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Carmen Ortiz Mellet

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mario De la Mata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

María Isabel Garcia Moreno

9 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

José Manuel García Fernández

9 March 2020

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Julio Rodríguez-Lavado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Katsumi Higaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Eiji Nanba

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kousaku Ohno

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yoshiyuki Suzuki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

Organic and Biomolecular Chemistry

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

2289-2301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24589885%20AND%20SRC:MED&resulttype=core&format=json

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Glycosphingolipids--nature, function, and pharmacological modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Gaucher disease: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Phenotype, diagnosis, and treatment of Gaucher's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Gaucher disease: complexity in a "simple" disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pharmacological small molecules for the treatment of lysosomal storage disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Substrate reduction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pharmacotherapeutic strategies using small molecules for the treatment of glycolipid lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Glucocerebrosidase inhibitors for the treatment of Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pharmacological chaperones as therapeutics for lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Therapeutic approaches to protein-misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Functional screening of pharmacological chaperones via restoration of enzyme activity upon denaturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Rapid assembly of a library of lipophilic iminosugars via the thiol-ene reaction yields promising pharmacological chaperones for the treatment of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Binding of 3,4,5,6-Tetrahydroxyazepanes to the Acid-β-glucosidase Active Site: Implications for Pharmacological Chaperone Design for Gaucher Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Recent developments in design and synthesis of bicyclic azasugars, carbasugars and related molecules as glycosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pharmacological chaperone therapy for Gaucher disease: a patent review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Castanospermine-trehazolin hybrids: a new family of glycomimetics with tuneable glycosidase inhibitory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Pseudoamide-type pyrrolidine and pyrrolizidine glycomimetics and their inhibitory activities against glycosidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Synthesis and biological evaluation of guanidine-type iminosugars.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

sp2-Iminosugar O-, S-, and N-glycosides as conformational mimics of α-linked disaccharides; implications for glycosidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Fullerene-sp2-iminosugar balls as multimodal ligands for lectins and glycosidases: a mechanistic hypothesis for the inhibitory multivalent effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

A Fluorescent sp2-iminosugar with pharmacological chaperone activity for gaucher disease: synthesis and intracellular distribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Cyclodextrins and their pharmaceutical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Macrophage receptors and immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Design, synthesis and biological evaluation of carbohydrate-functionalized cyclodextrins and liposomes for hepatocyte-specific targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Multivalent glycoconjugates as anti-pathogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Sweet carbon nanostructures: carbohydrate conjugates with carbon nanotubes and graphene and their applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Multivalent glyco(cyclo)peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Multivalency in heterogeneous glycoenvironments: hetero-glycoclusters, -glycopolymers and -glycoassemblies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Multivalent glycoconjugate syntheses and applications using aromatic scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Dependence of concanavalin A binding on anomeric configuration, linkage type, and ligand multiplicity for thiourea-bridged mannopyranosyl-beta-cyclodextrin conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

(Pseudo)amide-linked oligosaccharide mimetics: molecular recognition and supramolecular properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Copper(II)-complex directed regioselective mono-p-toluenesulfonylation of cyclomaltoheptaose at a primary hydroxyl group position: an NMR and molecular dynamics-aided design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Comparative studies on lectin-carbohydrate interactions in low and high density homo- and heteroglycoclusters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Probing carbohydrate-lectin recognition in heterogeneous environments with monodisperse cyclodextrin-based glycoclusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D

Fibroblast screening for chaperone therapy in beta-galactosidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3OB42530D